| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.731 | 7.526 | - | 767 | 3.414 | 9.241 | 8.511 | - | - | 0 |
| Total Income - EUR | 3.095 | 4.758 | - | 332 | 3.414 | 9.241 | 8.511 | - | - | 0 |
| Total Expenses - EUR | 2.541 | 4.118 | - | 181 | 1.503 | 591 | 3.393 | - | - | 0 |
| Gross Profit/Loss - EUR | 555 | 640 | - | 151 | 1.911 | 8.650 | 5.118 | - | - | 0 |
| Net Profit/Loss - EUR | 358 | 414 | - | 129 | 1.809 | 8.373 | 4.862 | - | - | 0 |
| Employees | 0 | 1 | - | 0 | 0 | 0 | 0 | - | - | 0 |
Check the financial reports for the company - Bio Terra Topoloveni Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 0 | - | - | 0 |
| Current Assets | 4.669 | 3.131 | - | 2.315 | 3.964 | 12.251 | 16.823 | - | - | 3.810 |
| Inventories | 3.124 | 2.031 | - | 1.574 | 223 | 0 | 0 | - | - | 0 |
| Receivables | 953 | 695 | - | 465 | 1.264 | 682 | 4.346 | - | - | 0 |
| Cash | 592 | 405 | - | 276 | 2.477 | 11.569 | 12.477 | - | - | 3.810 |
| Shareholders Funds | 928 | 1.333 | - | 2.093 | 3.862 | 12.161 | 16.754 | - | - | 3.810 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | - | - | 40 |
| Debts | 3.741 | 1.798 | - | 222 | 102 | 90 | 69 | - | - | 0 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | - | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1039 - 1039" | |||||||||
| CAEN Financial Year |
1039
|
|||||||||
Comments - Bio Terra Topoloveni Srl